286 related articles for article (PubMed ID: 28592274)
1. The magnitude and correlates of Parvovirus B19 infection among pregnant women attending antenatal clinics in Mwanza, Tanzania.
Mirambo MM; Maliki F; Majigo M; Mushi MF; Moremi N; Seni J; Matovelo D; Mshana SE
BMC Pregnancy Childbirth; 2017 Jun; 17(1):176. PubMed ID: 28592274
[TBL] [Abstract][Full Text] [Related]
2. Magnitude of the Cytomegalovirus infection among pregnant women attending antenatal clinics in the city of Mwanza, Tanzania.
Chibwe E; Mirambo MM; Kihunrwa A; Mshana SE
BMC Res Notes; 2017 Sep; 10(1):489. PubMed ID: 28931421
[TBL] [Abstract][Full Text] [Related]
3. Parvovirus B19 antibodies and correlates of infection in pregnant women attending an antenatal clinic in central Nigeria.
Emiasegen SE; Nimzing L; Adoga MP; Ohagenyi AY; Lekan R
Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):227-31. PubMed ID: 21537685
[TBL] [Abstract][Full Text] [Related]
4. Human B19 parvovirus infection in an obstetric population. A prospective study determining fetal outcome.
Guidozzi F; Ballot D; Rothberg AD
J Reprod Med; 1994 Jan; 39(1):36-8. PubMed ID: 8169914
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo State, Nigeria.
Abiodun I; Opaleye OO; Ojurongbe O; Fagbami AH
J Infect Dev Ctries; 2013 Dec; 7(12):946-50. PubMed ID: 24334941
[TBL] [Abstract][Full Text] [Related]
6. [Parvovirus B19 infection: the general aspects and gestational problems].
Di Stefano L; Carta G; Barnabei R; Tomei E; Toro G; Moscarini M
Minerva Ginecol; 1995 Apr; 47(4):121-5. PubMed ID: 7644092
[TBL] [Abstract][Full Text] [Related]
7. Human parvovirus B19 in Iranian pregnant women: a serologic survey.
Khameneh ZR; Hanifian H; Barzegari R; Sepehrvand N
Indian J Pathol Microbiol; 2014; 57(3):442-4. PubMed ID: 25118740
[TBL] [Abstract][Full Text] [Related]
8. Primary and secondary infection with human parvovirus B19 in pregnant women in South Africa.
Schoub BD; Blackburn NK; Johnson S; McAnerney JM
S Afr Med J; 1993 Jul; 83(7):505-6. PubMed ID: 8211491
[TBL] [Abstract][Full Text] [Related]
9. Sero-prevalence and factors associated with Toxoplasma gondii infection among pregnant women attending antenatal care in Mwanza, Tanzania.
Mwambe B; Mshana SE; Kidenya BR; Massinde AN; Mazigo HD; Michael D; Majinge C; Groß U
Parasit Vectors; 2013 Aug; 6():222. PubMed ID: 23915834
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of parvovirus B19 among pregnant women in Tripoli, Libya.
Elnifro E; Nisha AK; Almabsoot M; Daeki A; Mujber N; Muscat J
J Infect Dev Ctries; 2009 Apr; 3(3):218-20. PubMed ID: 19759477
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of antibody to human parvovirus B19 in pregnant women in Kuwait.
Maksheed M; Pacsa AS; Essa SS; Ahmed MA; Monem RA; Surkouh M
Acta Trop; 1999 Oct; 73(3):225-9. PubMed ID: 10546839
[TBL] [Abstract][Full Text] [Related]
12. Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany.
Enders M; Weidner A; Enders G
Epidemiol Infect; 2007 May; 135(4):563-9. PubMed ID: 17064457
[TBL] [Abstract][Full Text] [Related]
13. Parvovirus B19 Seroprevalence in Women with Bad Obstetric History in Kirkuk.
Alsamarai AM; Hassan HM; Alsamarai MA; Aljumaili ZK
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(4):359-366. PubMed ID: 34315400
[TBL] [Abstract][Full Text] [Related]
14. Maternal human parvovirus B19 infection and the risk of fetal death and low birthweight: a case-control study within 35 940 pregnant women.
Sarfraz AA; Samuelsen SO; Bruu AL; Jenum PA; Eskild A
BJOG; 2009 Oct; 116(11):1492-8. PubMed ID: 19769750
[TBL] [Abstract][Full Text] [Related]
15. The seroprevalence of parvovirus B19 infection among to-be-married girls, pregnant women, and their neonates in Shiraz, Iran.
Ziyaeyan M; Rasouli M; Alborzi A
Jpn J Infect Dis; 2005 Apr; 58(2):95-7. PubMed ID: 15858287
[TBL] [Abstract][Full Text] [Related]
16. [The frequency of human parvovirus B19 infections in Vojvodina].
Milosević V; Jerant-Patić V; Hrnjaković-Cvjetković I; Vukmanović-Papuga M; Jelena RT; Kovacević G
Med Pregl; 2007; 60(11-12):575-9. PubMed ID: 18666599
[TBL] [Abstract][Full Text] [Related]
17. Incidence of parvovirus B19 infection among an unselected population of pregnant women in the Netherlands: A prospective study.
van Gessel PH; Gaytant MA; Vossen AC; Galama JM; Ursem NT; Steegers EA; Wildschut HI
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):46-9. PubMed ID: 16406220
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of parvovirus B19 specific antibody in pregnant women with spontaneous abortion.
Rahbar N; Vali Zadeh S; Ghorbani R; Kheradmand P
Acta Med Iran; 2015; 53(3):168-72. PubMed ID: 25796023
[TBL] [Abstract][Full Text] [Related]
19. Adverse pregnancy outcomes among pregnant women with acute Rubella infections in Mwanza city, Tanzania.
Mirambo MM; Aboud S; Majigo M; Groβ U; Mshana SE
Int J Infect Dis; 2019 Jan; 78():72-77. PubMed ID: 30391418
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of anti-parvovirus B19 IgG and IgM and parvovirus B19 viremia in pregnant women in an urban area of Northern Italy.
De Paschale M; Pavia C; Cerulli T; Cagnin D; Manco MT; Belvisi L; Paganini A; Pogliani L; Ceriani E; Porta A; Parola L; Mirri P; Osnaghi B; Vismara L; Clerici P
J Med Virol; 2022 Nov; 94(11):5409-5414. PubMed ID: 35764590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
